Search results
SMA Solar shares fall 30% after profit warning
Reuters via Yahoo Finance Canada· 4 weeks agoShares in German solar power parts supplier SMA Solar Technology AG plunged by 31.7% on Wednesday after it cut its profit guidance on Tuesday night, citing political uncertainty. SMA Solar expects ...
AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
Zacks via Yahoo Finance Canada· 2 months agoAstraZeneca AZN announced its long-term plan to generate $80 billion in total revenues by 2030,...
Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues
Zacks via Yahoo Finance Canada· 2 months agoEsperion Therapeutics, Inc. ESPR reported earnings of 34 cents per share in the first quarter of...
Absci (ABSI) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance Canada· 2 months agoAbsci Corporation ABSI is scheduled to report first-quarter 2024 results on May 14. Let's see how...
WEX Inc. (NYSE:WEX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance Canada· 3 months agoWEX Inc. (NYSE:WEX) Q1 2024 Earnings Call Transcript April 25, 2024 WEX Inc. misses on earnings expectations. Reported EPS is $3.46 EPS, expectations...
GSK Announces FDA Acceptance of New Meningococcal Jab BLA
Zacks via Yahoo Finance Canada· 3 months agoThe approval of GSK's 5-in-1 meningococcal ABCWY vaccine candidate, MenABCWY, could provide the...
J&J (JNJ) Q1 Earnings Beat Estimates, Sales Miss, MedTech Soft
Zacks via Yahoo Finance Canada· 3 months agoJohnson & Johnson’s JNJ first-quarter 2024 earnings came in at $2.71 per share, which beat the Zacks...
ANI Pharmaceuticals (ANIP) Stock Moves -0.13%: What You Should Know
Zacks via Yahoo Finance Canada· 3 months agoANI Pharmaceuticals (ANIP) closed the latest trading day at $66.96, indicating a -0.13% change from...
Palatin (PTN) Up 15% on Results From Dry Eye Disease Study
Zacks via Yahoo Finance Canada· 3 months agoA late-stage study data shows that treatment with Palatin's (PTN) experimental dry eye disease drug...
Vertex (VRTX) Moves Kidney Disease Drug to Phase 3 Development
Zacks via Yahoo Finance Canada· 3 months agoVertex (VRTX) advances inaxaplin to late-stage development. It will evaluate the drug in lower age...